1.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI, Other Protocol IDs: 1603.00, FHCRC-1603.00, NCI-H02-0092, CDR0000256871, NCT00045292
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 2 to 18 Sponsor: Other Protocol IDs: H9912, VALACYCLOVIR SINGLE DOSE, NCT00042328
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BrTK02, 5R44CA107745, NCT00589875
|
|
4.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PaTK01, 1R43CA119847, NCT00638612
|
|
5.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BrTK01, 5R44CA107745, NCT00751270
|